Skip to main content
. 2020 Jun;26(6):1174–1181. doi: 10.3201/eid2606.191141

Table 4. All-cause 30-day and 12-month mortality among adult patients with iGBS infection in England, 2015–2016*.

Age, y Male patients
Female patients, excluding pregnancy-related episodes
No. iGBS episodes All-cause deaths within 30 d, no. (%) All-cause deaths within 1 y, no. (%) Median (IQR) time to death, d No. iGBS episodes All-cause deaths within 30 d, no. (%) All-cause deaths within 1 y, no. (%) Median (IQR) time to death, d
15–19 6 0 3 (50.0) 39 (33–170) 6 2 (33.3) 2 (33.3) 4 (2–6)
20–29 27 1 (3.7) 2 (7.4) 144 (2–285) 22 0 (0.0) 2 (9.1) 179 (33–325)
30–39 59 4 (6.8) 7 (11.9) 3 (1–159) 39 1 (2.6) 2 (5.1) 58 (2–113)
40–49 120 14 (11.7) 27 (22.5) 26 (2–68) 84 3 (3.6) 8 (9.5) 37 (15–124)
50–59 212 21 (9.9) 44 (20.8) 39 (12–135) 127 3 (2.4) 15 (11.8) 80 (40–177)
60–69 281 21 (7.5) 51 (18.1) 45 (11–168) 193 21 (10.9) 46 (23.8) 72 (3–177)
70–79 310 38 (12.3) 93 (30.0) 57 (13–145) 235 34 (14.5) 66 (28.1) 30 (8–119)
>80
359
77 (21.4)
177 (49.3)
41 (10–188)

426
73 (17.1)
186 (43.7)
54 (8–136)
Total 1,374 176 (12.8) 404 (29.4) 44 (10–167) 1,132 137 (12.1) 327 (28.9) 53 (8–138)

*iGBS, invasive group B Streptococcus; IQR, interquartile range.